We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+19.96%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$13.1B
AUM Growth
+$1.42B
(+12%)
Cap. Flow
-$642M
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
18.52%
Holding
284
New
44
Increased
49
Reduced
142
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$163M |
| 2 |
Caterpillar
CAT
|
+$85.4M |
| 3 |
Analog Devices
ADI
|
+$53.7M |
| 4 |
Advance Auto Parts
AAP
|
+$39.7M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$37.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$142M |
| 2 |
Costco
COST
|
+$77.5M |
| 3 |
Vail Resorts
MTN
|
+$76.9M |
| 4 |
CELG
Celgene Corp
CELG
|
+$73.2M |
| 5 |
Mettler-Toledo International
MTD
|
+$67.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.26% |
| 2 | Healthcare | 16.35% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Industrials | 12.97% |
| 5 | Financials | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Entegris
ENTG
$21.8B
| $26.7M | 0.2% |
+748,790
| New | +$24.9M |
|
152
WEX
WEX
$6.46B
| $26.5M | 0.2% |
138,176
+16,990
| +14% | +$2.87M |
|
153
Trex
TREX
$4.93B
| $26.2M | 0.2% |
851,720
+88,960
| +12% | +$3.11M |
|
154
Avnet
AVT
$7.94B
| $26.1M | 0.2% |
+601,420
| New | +$25.4M |
|
155
American Eagle Outfitters
AEO
$2.97B
| $25.7M | 0.2% |
1,161,275
-47,930
| -4% | -$985K |
|
156
8x8 Inc
EGHT
$327M
| $25.7M | 0.2% |
1,271,710
+208,570
| +20% | +$4.08M |
|
157
Ironwood Pharmaceuticals
IRWD
$701M
| $25.5M | 0.19% |
2,246,958
-111,048
| -5% | -$1.24M |
|
|
NUAN
158
DELISTED
Nuance Communications, Inc.
NUAN
| $25M | 0.19% |
1,702,210
-85,430
| -5% | -$1.18M |
|
159
Strategic Education
STRA
$1.86B
| $24.4M | 0.19% |
+185,939
| New | +$22.7M |
|
|
NEWR
160
DELISTED
New Relic, Inc.
NEWR
| $23.7M | 0.18% |
239,969
-3,645
| -1% | -$361K |
|
161
Viavi Solutions
VIAV
$10B
| $23.5M | 0.18% |
1,901,469
-92,475
| -5% | -$1.08M |
|
162
Agios Pharmaceuticals
AGIO
$1.91B
| $23.1M | 0.18% |
+342,680
| New | +$20M |
|
|
WNS
163
DELISTED
WNS Holdings
WNS
| $22.7M | 0.17% |
425,480
-20,795
| -5% | -$1.04M |
|
164
Performance Food Group
PFGC
$18B
| $22.4M | 0.17% |
+565,405
| New | +$20.7M |
|
|
ACIA
165
DELISTED
Acacia Communications Inc
ACIA
| $22.4M | 0.17% |
390,565
-122,155
| -24% | -$5.84M |
|
166
Green Dot
GDOT
$759M
| $22.1M | 0.17% |
365,160
+130,457
| +56% | +$9.1M |
|
167
Children's Place
PLCE
$58.9M
| $22.1M | 0.17% |
+227,045
| New | +$20.7M |
|
|
CCMP
168
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $22.1M | 0.17% |
+196,997
| New | +$20.4M |
|
169
Old Dominion Freight Line
ODFL
$44B
| $21M | 0.16% |
437,226
-6,675
| -2% | -$312K |
|
|
MTOR
170
DELISTED
MERITOR, Inc.
MTOR
| $21M | 0.16% |
+1,032,420
| New | +$21M |
|
|
XENT
171
DELISTED
Intersect ENT, Inc
XENT
| $21M | 0.16% |
652,781
-33,075
| -5% | -$1.02M |
|
172
Bank of N.T. Butterfield & Son
NTB
$2.44B
| $20.7M | 0.16% |
577,315
-30,160
| -5% | -$1.08M |
|
|
ZGNX
173
DELISTED
Zogenix, Inc.
ZGNX
| $20.7M | 0.16% |
375,685
-161,250
| -30% | -$7.67M |
|
174
DexCom
DXCM
$31.3B
| $20.1M | 0.15% |
676,432
-551,320
| -45% | -$19.4M |
|
|
CLVS
175
DELISTED
Clovis Oncology, Inc.
CLVS
| $20M | 0.15% |
+806,465
| New | +$20.2M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Westfield Capital Management held 284 positions worth $13.1B, up 12% from $11.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management withdrew a net $642M in Q1 2019, closing 38 positions and reducing 142 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Westfield Capital Management opened a new position in Bristol-Myers Squibb worth $156M.
- Westfield Capital Management's largest Q1 2019 buy was Bristol-Myers Squibb: 3,278,241 shares worth $156M.
- Westfield Capital Management added most to T-Mobile US in Q1 2019, an estimated $32.3M increase.
- Westfield Capital Management's biggest Q1 2019 reduction was Vail Resorts, cutting an estimated $76.9M.
- Westfield Capital Management fully exited Jazz Pharmaceuticals in Q1 2019, selling an estimated $142M.
- Westfield Capital Management's ten largest holdings make up 19% of its $13.1B portfolio in Q1 2019.
- Westfield Capital Management opened 44 new positions and closed 38 in Q1 2019.
- Westfield Capital Management's portfolio value rose 12% quarter-over-quarter to $13.1B.
Based on Westfield Capital Management's 13F filing for Q1 2019, filed 14 May 2019.